Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pregabalin Phonophoresis for Carpal Tunnel Syndrome Pain

NCT: NCT07613476 · ACTIVE_NOT_RECRUITING

NCT IDNCT07613476
StatusACTIVE_NOT_RECRUITING
Start Date2026-01-01
Completion2026-07-19

Brief Summary

Carpal tunnel syndrome (CTS) is a common condition caused by pressure on the median nerve in the wrist, leading to pain, numbness, and weakness in the hand. Oral medications for nerve pain can have significant side effects. This study tests a new, non-invasive approach. Pregabalin, a medication for neuropathic pain, will be mixed into a gel and delivered through the skin using therapeutic ultrasound, a method called phonophoresis. This avoids the digestive system and may reduce side effects. This randomized controlled trial will compare the effects of pregabalin phonophoresis against standard ultrasound therapy (without the drug) in 57 patients aged 20-40 with mild to moderate CTS. Treatments will occur 4 times per week for one month. Pain will be measured using the Numeric Pain Rating Scale, and hand function using the Boston Carpal Tunnel Questionnaire. The study aims to determine if pregabalin phonophoresis provides superior pain relief and functional improvement compared to ultrasound alone, offering a new, safe, and cost-effective physiotherapy treatment for CTS.

Frequently Asked Questions

What is Pregabalin Phonophoresis for Carpal Tunnel Syndrome Pain?

Pregabalin Phonophoresis for Carpal Tunnel Syndrome Pain is a clinical trial registered under NCT07613476. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07613476?

The current status of NCT07613476 (Pregabalin Phonophoresis for Carpal Tunnel Syndrome Pain) is: ACTIVE_NOT_RECRUITING.

When did Pregabalin Phonophoresis for Carpal Tunnel Syndrome Pain start?

Pregabalin Phonophoresis for Carpal Tunnel Syndrome Pain started on 2026-01-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.